key: cord-0900866-0cmhfqkr authors: Mejía-Melara, Quirino; González-Dávila, Santiago Elizandro; Jiménez-Leos, Martha Cecilia; Vera-Pineda, Raymundo; Flores-Ramírez, Ramiro title: Right Ventricular Thrombus in Transit in a patient with COVID-19 date: 2022-02-01 journal: J Emerg Med DOI: 10.1016/j.jemermed.2022.01.008 sha: 31aafcee978dfdc0c1d126d6b41fab33f26e684c doc_id: 900866 cord_uid: 0cmhfqkr nan Edgar Francisco Carrizales-Sepúlveda, MD 1* ; Quirino Mejía-Melara, MD 1 ; Santiago Elizandro González-Dávila, MD 2 ; Martha Cecilia Jiménez-Leos, MD 2 ; Raymundo Vera-Pineda, MD 1 ; Ramiro Flores-Ramírez, MD, PhD 1* . 1 All authors had full access to data and a roll in the preparation of this manuscript. A 62-year-old male presented with worsening respiratory distress. He had a history of uncontrolled diabetes mellitus and dyslipidemia and received two doses of COVID-19 adenovirus-vectored vaccine (ChAdOx1 nCoV-19) 4 months before presentation. Symptoms began 13 days before admission with headache, low-grade fever and malaise. He tested positive for COVID-19 and started treatment at home with supplementary oxygen and supportive measures. At day 13, he presented with worsening dyspnea and increasing oxygen requirements and was referred to our unit. During admission, he was found in respiratory distress was intubated and started treatment with Baricitinib, dexamethasone and prophylactic low-molecular-weight-heparin. During his first day of hospitalization, he experienced sudden hemodynamic collapse that required high doses of vasopressors. An electrocardiogram showed a right-bundle-branch block with an S1Q3T3 pattern. Although in the beginning of the pandemic COVID-19 was considered mainly a respiratory disease, the available evidence to date shows that there exist involvement of multiple organs and systems, and that the heart is one of the most important targets (1). In COVID-19 the RV is frequently involved showing dilation and subtle or overt dysfunction, which can be the result of the acute stress imposed over a thin-walled ventricle by severe lung involvement, mechanical ventilation (MV), ischemia and myocardial damage (1, 2) . In addition, there is strong growing evidence that indicates that patients with COVID-19 are at an increased risk of venous thromboembolism (VTE) (3, 4) . Recent studies have shown that symptomatic VTE is present in 1.09% of admitted patients with COVID-19, with more than 85% being PE (3). Other findings suggest that VTE can be present in 3.5% of the overall admitted patients with COVID-19, and 17% in those that are screened because of high clinical suspicion; in this study, higher levels of D-dimer and need for MV were found as strong risk factors for VTE (4) . Although the mechanisms that lead to an increased risk of VTE in patients with COVID-19 are still not fully elucidated, endothelial injury, immobilization in critically ill patients and some changes in circulating levels of prothrombotic factors might play a role in the pathogenesis. Echocardiography has shown to be useful in the diagnostic and therapeutic process of patients with PE and hemodynamic instability (5, 6) . Some of the signs of RV pressure overload can be detected with 2D echo without the need for M-mode or Doppler techniques; the detection of a dilated RV, the McConnell's sign and a thrombus can have a sensitivity of 80, 97 and 99% with a positive likelihood ratio of 4, 7.3 and 5, respectively (6) . A right ventricular thrombus in transit is considered an uncommon finding and can be detected in 2 -4% of patients with PE, being far more common in those with hypotension or signs of RV dysfunction (20%) (5, 6) . When present, it confirms the diagnosis of PE and carries a bad prognosis (5, 7) . A thrombus in transit has been previously reported in other patients with COVID-19 (8) . Point-of-care cardiac ultrasound has emerged as a valuable tool in the assessment of patients that present with shock and suspicion of PE (9) . It can detect with accuracy most of the signs of RV pressure overload such as RV dilation, D-shape, McConnell's sign, thrombus in transit, and inferior vena cava dilation; since it is portable and acquisition protocols are fast, it can shorten the times from presentation to diagnosis and treatment, which is associated with better outcomes (5, 10) . According to guidelines and recommendations, in patients with hemodynamic instability and suspected PE the presence of echocardiographic signs of RV pressure overload justify emergent reperfusion therapy with systemic thrombolysis, since it has shown to improve RV function and prognosis (5, 8) . Author contributions: All authors had full access to data and a role in the preparation of this manuscript. Echocardiographic Manifestations in COVID-19: A Review Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Role of echocardiography in managing acute pulmonary embolism Prevalence and prognostic significance of right-sided cardiac mobile thrombi in acute massive pulmonary embolism Ventricular Clot in Transit in COVID-19: Implications for the Pulmonary Embolism Response Team Make it SIMPLE: enhanced shock management by focused cardiac ultrasound Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes This article does not contain any studies with human participants or animals performed by any of the authors.